Amla and Cholesterol: What a 12-Week Trial Found
The vitamin C in amla gets the headlines, but some of the more interesting research on the fruit is about lipids. And unusually for a "superfruit," there is an actual randomized controlled trial to talk about.
The trial
Researchers ran a randomized, double-blind, placebo-controlled, multicenter trial in 98 adults with dyslipidemia (unhealthy blood-fat levels). Participants took 500 mg of amla (Emblica officinalis) extract twice daily, or a matching placebo, for twelve weeks (Upadya et al., BMC Complementary and Alternative Medicine, 2019).
By the end, the amla group showed significant reductions in total cholesterol, LDL cholesterol, triglycerides, and VLDL compared with placebo, along with an improvement in a composite measure of cardiovascular risk.
A twelve-week, placebo-controlled trial is a real piece of evidence. It is also one study, in one group, at one dose.
It is not just one study
A single trial is a data point, not a verdict. What strengthens the picture is that a later systematic review and meta-analysis of randomized trials found amla supplementation associated with lower LDL, total cholesterol, triglycerides, fasting glucose, and C-reactive protein, with higher HDL (Complementary Therapies in Medicine, 2023).
When an individual trial and a meta-analysis of many trials point the same way, that is worth more than either alone.
The caveats that keep it honest
- Extract, not fruit. The trials used concentrated amla extract at a defined dose, not a spoonful of pickle. You cannot assume the same effect from casual eating.
- Markers, not outcomes. Improving cholesterol numbers is not the same as preventing heart disease, and this evidence does not show that.
- Averages. Results vary between people.
- Not a treatment. If you are managing cholesterol, this is context for a conversation with your clinician, not a reason to change anything on your own.
The verdict
Genuinely promising, and genuinely bounded. Amla has better human lipid evidence than most fruits marketed for "heart health," anchored by a real randomized controlled trial and supported by meta-analysis. It is still an extract, still about markers, and still no substitute for medical care.
Keep reading: amla and blood sugar, amla for skin and hair, and, for the reading skills, how to read a supplement claim.
Liked the dig? Join the Almanac.
One story, one thing worth tasting, one honest verdict, one unhinged footnote. Weekly.